期刊文献+

CYP3A4基因多态性对药物代谢及其个体化给药的影响 被引量:12

Effect of CYP3A4 genetic polymorphism on drug metabolism and individualized therapy
下载PDF
导出
摘要 CYP3A4是一种重要的药物代谢酶,参与多种药物的体内代谢,该酶的活性在不同的体内,种族和联用药物之间存在着明显的差异。本文综述了CYP3A4酶的基因多态性对药物代谢的影响,以期为指导临床合理用药打下理论基础,确保临床合理用药的安全性和有效性。 CYP3A4 is an important drug metabolizing enzyme involved in the metabolism of a variety of drugs in vivo.The enzymatic activity is significantly different in different individuals and races.In this paper,we summarized the effect of CYP3A4 genetic polymorphism on drug metabolism,in order to lay down a theory foundation for the guidance in clinical rational administration,ensure the safety and effectiveness of clinical usage.
出处 《海峡药学》 2013年第4期1-3,共3页 Strait Pharmaceutical Journal
关键词 CYP3A4 基因多态性 药物代谢 个体化用药 CYP3A4 Genetic polymorphism Drug metabolism Individualized therapy
  • 相关文献

参考文献14

  • 1Venkatakrishnan K, Von Moltke L L, Greenblatt D J. Human drug me- tabolism and the cytochromes P450: application and relevance of invitro models[ J]. J Clin Pharmacol,2001,41 (11) :1149-1179.
  • 2Wang R W, Newton D J,Scheri T D,et aL Human cytochrome P450 3A4-catalyzed testosterone 6 beta-hydroxylation and erythromycin N- demethylation. Competition during catalysis [ J ]. Drug Metal) Dispos, 1997,25(4) :502-507.
  • 3Wojnowski L Genetics of the variable expression of CYP3A in humans [ J ]. Ther Drug Monit,2004,26 (2) : 192-199.
  • 4Hashlmoto H,Tolde K,Kitamura R,et aL C, ene structure of CYF3A4,an adult-specific form of cytoohrome P450 in human livers, and its tran- scriptional control[ J]. Eur J Bioobem,1993,218(2) :585-595.
  • 5Hersh E V, Moore P A. Drug interactions in dentistry:the importance of knowing your CYPs[J]. J Am Dent Assoc,2004,135(3) :298-311.
  • 6Hughes C A, Freitas A, Miedzinski L J. Interaction between lopinavir/ ritonavir and warfarin[ J]. CMAJ ,2007,177 (4) :357-359.
  • 7Malaty L I, Kupor J J. Drug interactions of HIV protease inhibitors [J]. Drug Saf,1999,20(2) :147-169.
  • 8Dutreix C, Peng B, Mehring G, et al. Phannacokinetic interaction be- tween keteconazole and imatinib mesylate (Glivec) in healthy subjects [J]. Cancer Chemother Pharmacol,2004,54(4) :290-294.
  • 9Harkey M R,Henderson G L,Gesshwin M E,et al. Variability in com- mercial ginseng products:an analysis of 25 preparations[ J ]. Am J Clin Nutr,2001,73 (6) : 1101-1106.
  • 10Mills E,Wilson K, Clarke M, et al. Milk thistle and indinavir: a ran- domized controlled phannacokinetics study and recta-analysis[ J ]. Eur J Clin Pharmaco1,2005,61 ( 1 ) : 1-7.

同被引文献149

引证文献12

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部